Natus Medical Earnings: The Stock Has Some Upside Left
Andy Batts - at Seeking Alpha - Thu Feb 12, 9:43AM CST
BABY: 36.96 (-0.03)
Natus Medical Up 42.4% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Wed Feb 11, 9:19AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 10 months, Natus Medical has returned 42.39% as of today's recent price of $37.15.
BABY: 36.96 (-0.03)
Uptrend Call Working As Natus Medical Stock Rises 41.4% (BABY)
Comtex SmarTrend(R) - Tue Feb 03, 5:06PM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 10 months, Natus Medical has returned 41.36% as of today's recent price of $36.88.
BABY: 36.96 (-0.03)
Natus Medical (BABY) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:20PM CST
Provider of newborn care and neurology healthcare products, Natus Medical Inc. (BABY), reported adjusted earnings per share (EPS) of 40 cents in the fourth quarter of 2014
BABY: 36.96 (-0.03), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), EW: 134.23 (+1.89)
Natus Medical Has The Right Growth Metrics BABY
Chris Katje - at Seeking Alpha - Thu Jan 29, 11:10AM CST
BABY: 36.96 (-0.03)
Natus Medical's (BABY) CEO James Hawkins on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Jan 28, 4:24PM CST
BABY: 36.96 (-0.03)
Natus Medical Inc. Serves Up a New Business Model
Brian Orelli, The Motley Fool - Motley Fool - Wed Jan 28, 2:26PM CST
Natus Medical continues to fire on all cylinders. It's hard to find something to complain about the medical device maker specializing in neurology and care for newborns. Even the numbers that don't look good have positive causes. Take, for...
BABY: 36.96 (-0.03)
Natus Medical Incorporated (BABY) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Jan 28, 9:55AM CST
BABY: 36.96 (-0.03)
Natus Medical raises guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:09AM CST
BABY: 36.96 (-0.03)
Natus Medical beats 4Q profit forecasts
Automated Insights - Wed Jan 28, 7:52AM CST
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported fourth-quarter earnings of $9.9 million.
BABY: 36.96 (-0.03)
Natus Medical beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 6:03AM CST
BABY: 36.96 (-0.03)
Natus Medical Announces Record Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Wed Jan 28, 6:00AM CST
- Increases 2015 revenue and earnings guidance
BABY: 36.96 (-0.03)
Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 4:30PM CST
ARLP: 39.29 (+1.84), CRS: 42.01 (+0.81), MKC: 74.64 (+0.33), PCH: 39.96 (-0.04), RYAM: 17.58 (+0.36), EAT: 59.16 (-0.18), ENR: 138.49 (+3.42), AEP: 57.83 (-0.15), PGR: 27.11 (+0.06), BABY: 36.96 (-0.03), CFR: 69.19 (+1.16), ROL: 33.74 (-0.01), ROK: 117.90 (+1.02), RES: 13.36 (+0.93), HES: 76.83 (+2.12), TROW: 82.45 (+0.17), IP: 57.31 (+0.12), GNTX: 17.81 (+0.27), TXT: 44.68 (+0.49), BA: 149.73 (+1.64), HCBK: 9.92 (+0.03), GIB: 41.90 (+0.05), ADT: 38.21 (+0.11), TUP: 72.53 (+0.44), KLIC: 16.00 (-0.30), AME: 51.41 (+0.80), KNX: 32.26 (+0.88), STJ: 67.48 (+0.65), PX: 126.89 (+1.53), STM: 8.91 (-0.21), MDP: 54.72 (+0.19), GD: 137.61 (-0.54), ABMD: 60.39 (+0.46), MKTX: 81.22 (-0.66), ACAT: 39.00 (+1.31), SEIC: 43.20 (+0.07), BOKF: 59.26 (+0.19), CVLT: 43.68 (-0.05), ANTM: 141.05 (-0.95), HTCH: 3.71 (+0.09), MDC: 27.38 (-0.24), AHGP: 53.10 (+1.92), TEL: 70.76 (+0.38), RDWR: 20.85 (+0.42), BAH: 30.16 (+0.18), FCAU: 14.53 (+0.06), SPIL: 8.69 (+0.14), EVER: 18.26 (-0.01), ABC: 100.34 (+0.51), MTOR: 14.33 (+0.38)
Shares of BABY Up 41.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 27, 11:12AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 9 months, Natus Medical has returned 41.20% as of today's recent price of $36.84.
BABY: 36.96 (-0.03)
Natus Medical buys Global Neuro-Diagnostics to enter the neurodiagnostic services market
M2 - Tue Jan 27, 4:22AM CST
Healthcare company Natus Medical (NasdaqGS:BABY) revealed on Monday that it has completed its acquisition of Global Neuro-Diagnostics (GND), marking its entry into the neurodiagnostic services market.
BABY: 36.96 (-0.03)
Natus Medical Announces Entry Into Neurodiagnostic Services Market
GlobeNewswire - Mon Jan 26, 6:00AM CST
? Acquires Global Neuro-Diagnostics ("GND"
BABY: 36.96 (-0.03)
Echo Therapeutics Restores Pact with MTIA, Issues Patent - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 4:05PM CST
Echo Therapeutics Inc. (ECTE), a firm engaged in the development of transdermal skin permeation and diagnostic medical devices, recently announced re-establishment of its contract with Medical Technologies Innovation Asia (MTIA), Ltd.
ECTE: 2.62 (+0.06), BABY: 36.96 (-0.03), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Natus Medical's a Strong Buy on Expanding Product Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 12:00PM CST
On Jan 22, 2015, Zacks Investment Research raised Natus Medical Inc. (BABY) to a Zacks Rank #1 (Strong Buy).
XENT: 23.06 (+0.46), BABY: 36.96 (-0.03), JNJ: 99.62 (+1.18), INGN: 33.53 (+2.32)
Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Wed Jan 21, 7:32AM CST
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention and produce gains; and one such company that might be well-positioned for future earnings growth is Natus Medical.
BABY: 36.96 (-0.03)